MyFinsight
Home
About
Contact
Back
Income Statement
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
source: myfinsight.com
Download
Download image
APOKYN
$12,820K
GOCOVRI
$36,660K
ONAPGO
$1,604K
Oxtellar XR
$11,637K
Qelbree
$77,547K
Trokendi Xr
$11,193K
Manufactured Product Other
$6,534K
Royalty License And
Other Revenue
$7,458K
Product
$157,995K
Interest and other
income, net
$4,528K
(21.30%↑ Y/Y)
Total revenues
$165,453K
(-1.71%↓ Y/Y)
Total other income
(expense), net
$4,528K
(21.30%↑ Y/Y)
Operating earnings
$12,141K
(-46.20%↓ Y/Y)
Total costs and
expenses
$153,312K
(5.18%↑ Y/Y)
Earnings before income
taxes
$16,669K
(-36.62%↓ Y/Y)
Income tax expense
(benefit)
-$5,830K
(-191.29%↓ Y/Y)
Amortization of intangible
assets
$20,819K
(3.54%↑ Y/Y)
Cost of goods sold
$16,827K
(-6.08%↓ Y/Y)
Research and development
$22,115K
(-15.54%↓ Y/Y)
Selling, general and
administrative
$93,551K
(8.90%↑ Y/Y)
Net earnings
$22,499K
(12.97%↑ Y/Y)
Back